Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
about
Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrumFirst detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.New methods to assess susceptibilities of Aspergillus isolates to caspofungin.Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulansConcentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus sppComparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidiaNewer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusIn Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus SpeciesThe putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulenceInterlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesTrends in antifungal susceptibility testing using CLSI reference and commercial methods.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.In vitro susceptibility testing in Aspergillus species: an update.Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole.In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.Glucan Synthase Inhibitors
P2860
Q33753320-433E98B3-C29D-44A8-9F8F-F733B778F8E4Q34057414-BAA3A2E3-BF77-4D2F-A62A-2E97DCE4E6F6Q34455699-0D2960CD-2FCB-4EC4-85F1-A8BA6A45AB5EQ34621506-1FB9A36A-3D8D-4AC0-A7C6-3036EC35E6B7Q34956645-5E0F2D58-98A8-499E-A916-A232EA75CAEFQ35215384-88129B2E-29A1-40D0-8D7D-690BBB1C0B0FQ35647724-B26AC379-B222-4F8E-841B-2A3F73310191Q35870651-06067B80-EB64-4CF9-844A-2DACCB00E62CQ35913719-D8341767-09D0-4A32-AB97-7F8AAF9262AFQ36066784-ACAC502F-B03B-4D8E-A568-1071895FCB8DQ36171554-32E2BB42-6B5F-4F2F-9BF7-D22B695E566CQ36422666-A53D3BFD-B0E9-4FD4-BF95-9DB0BD25F8EDQ36491819-7636AABC-3751-4933-B806-4CCD353CC338Q36492208-CB86E5FE-1583-41F6-832A-D09F0FE1C348Q36933432-D14E778C-C562-4AE7-8977-D1E89D1DEB1AQ36939017-E1232B9D-8478-4A5A-BCB4-86E7F6331719Q37157546-A1274571-91DC-4029-BEA0-AAE1C58B62B9Q37557695-1F7E2AF4-3535-47F8-8B2F-CC8A54BC9C9DQ37608276-2BF750C1-8396-431D-AEEB-2ADCF8AD1D3DQ37742178-4E7B1ADF-A79B-4249-BCB5-BBE233FBE83DQ38609513-4392A7EE-5822-4BD4-A357-8E2366F8CE46Q38868375-10F33A7F-F51A-4A36-B12C-DFEB619F5B46Q39755498-5F3C08EB-BF6C-46CF-BB67-AE6A06591519Q39913400-AAE430D3-2C30-4972-966A-68664373F45DQ41869129-746A8636-CCA5-4A74-A4C9-2D709116719AQ41938809-96CF49CB-ADB7-4790-81CB-595D1E8A56B2Q42107963-77BEF2E2-ABF7-4AD2-A848-83D2B22565E2Q42111761-B71218C8-F969-4EA9-A343-CB256E3C16C7Q42116260-B2173FA3-B704-433B-AD03-D846E93E6692Q42286250-D39481B8-A8F7-4F0D-8C4E-5474A2F7EE56Q42432176-BFE348F8-0A29-4A58-9401-BE19BEDE34AAQ42910172-F5B6A3F1-7C53-400A-AE31-1F0E7C7450A1Q50963535-3F1FD67A-47C6-40ED-A3F6-83DC93506C5BQ51037587-17DD90C6-E4AB-4D08-BB32-1197B24D87A5Q58033533-7AB1EFB2-FC15-40CE-94C0-78D956440F05
P2860
Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@ast
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@en
Evaluation of broth microdilut ...... us spp. to caspofungin acetate
@nl
type
label
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@ast
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@en
Evaluation of broth microdilut ...... us spp. to caspofungin acetate
@nl
prefLabel
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@ast
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@en
Evaluation of broth microdilut ...... us spp. to caspofungin acetate
@nl
P2860
P1476
Evaluation of broth microdilut ...... caspofungin acetate (MK-0991).
@en
P2093
Ana Espinel-Ingroff
P2860
P304
P356
10.1128/JCM.41.1.403-409.2003
P407
P577
2003-01-01T00:00:00Z